Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
55.5M
-
Number of holders
-
107
-
Total 13F shares, excl. options
-
33.2M
-
Shares change
-
-1.52M
-
Total reported value, excl. options
-
$103M
-
Value change
-
-$5.02M
-
Put/Call ratio
-
0.69
-
Number of buys
-
45
-
Number of sells
-
-52
-
Price
-
$3.11
Significant Holders of Voyager Therapeutics, Inc. - Common Stock, $0.001 par value (VYGR) as of Q2 2025
130 filings reported holding VYGR - Voyager Therapeutics, Inc. - Common Stock, $0.001 par value as of Q2 2025.
Voyager Therapeutics, Inc. - Common Stock, $0.001 par value (VYGR) has 107 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 33.2M shares
of 55.5M outstanding shares and own 59.79% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (5.73M shares), ARMISTICE CAPITAL, LLC (4.8M shares), EcoR1 Capital, LLC (3.92M shares), VANGUARD GROUP INC (3.21M shares), Vestal Point Capital, LP (1.48M shares), DIMENSIONAL FUND ADVISORS LP (1.42M shares), GEODE CAPITAL MANAGEMENT, LLC (1.12M shares), Erste Asset Management GmbH (1.12M shares), MILLENNIUM MANAGEMENT LLC (903K shares), and STATE STREET CORP (894K shares).
This table shows the top 107 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.